{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T14:25:56Z","timestamp":1782051956834,"version":"3.54.5"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The aim of this review is to provide a practical and updated summary on healthcare-associated central nervous system infections and their management.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The term \u2018healthcare-associated ventriculitis and meningitis\u2019 has recently been coined and clinical practical guidelines have been published on the management of these nosocomial infections. Many aspects have still to be further investigated (e.g. cerebrospinal fluid biomarkers, indications for novel antibiotics, intrathecal antimicrobial regimens).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Clinicians should maintain a high index of suspicion for healthcare-associated central nervous system infections in patients with specific risk factors (i.e. recent neurosurgery, cerebrospinal shunts, drains or implantable devices, head\/spinal traumatic events), taking into account systemic signs, and alterations in microbiological, imaging, cerebrospinal fluid findings. The diagnosis is often difficult to confirm because of reduced levels of consciousness or coma. Both Gram-positive and Gram-negative (often multidrug-resistant or even pandrug-resistant) microorganisms may be the cause. Selection of antibiotics must consider susceptibility and penetration into the central nervous system. Ineffective treatments are frequent, and mortality can reach 60%. Future research should focus on the diagnostic performance of biomarkers and on the use of novel antimicrobial regimens, especially for the treatment of difficult to treat infections.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aco.0000000000001167","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T12:00:58Z","timestamp":1660046458000},"page":"549-554","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Healthcare-associated central nervous system infections"],"prefix":"10.1097","volume":"35","author":[{"given":"Mariachiara","family":"Ippolito","sequence":"first","affiliation":[{"name":"Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo"},{"name":"Department of Anaesthesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Giarratano","sequence":"additional","affiliation":[{"name":"Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo"},{"name":"Department of Anaesthesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cortegiani","sequence":"additional","affiliation":[{"name":"Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo"},{"name":"Department of Anaesthesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"R1-20250601","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMra052116","article-title":"Community-acquired bacterial meningitis in adults","volume":"354","author":"van de Beek","year":"2006","journal-title":"N Engl J Med"},{"key":"R2-20250601","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4266\/acc.2021.01151","article-title":"Nosocomial meningitis in intensive care: a 10-year retrospective study and literature review","volume":"37","author":"Valdoleiros","year":"2022","journal-title":"Acute Crit Care"},{"key":"R3-20250601","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1413-8670(10)70090-8","article-title":"Mortality rate in patients with nosocomial acinetobacter meningitis from a Brazilian hospital","volume":"14","author":"Tuon","year":"2010","journal-title":"Braz J Infect Dis"},{"key":"R4-20250601","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 Infectious Diseases Society of America's Clinical Practice Guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R5-20250601","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra0804573","article-title":"Nosocomial bacterial meningitis","volume":"362","author":"van de Beek","year":"2010","journal-title":"N Engl J Med"},{"key":"R6-20250601","first-page":"e19069","article-title":"Healthcare-associated ventriculitis and meningitis: a retrospective analysis","volume":"13","author":"Coelho","year":"2021","journal-title":"Cureus"},{"key":"R7-20250601","first-page":"ofw077","volume":"3","author":"Srihawan","year":"2015","journal-title":"Clinical characteristics and predictors of adverse outcome in adult and pediatric patients with healthcare-associated ventriculitis and meningitis"},{"key":"R8-20250601","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"R9-20250601","doi-asserted-by":"crossref","first-page":"ofz050","DOI":"10.1093\/ofid\/ofz050","article-title":"Impact of antibiotic therapy in the microbiological yield of healthcare-associated ventriculitis and meningitis","volume":"6","author":"Rogers","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R10-20250601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0260551","article-title":"Central nervous system infection in the intensive care unit: development and validation of a multiparameter diagnostic prediction tool to identify suspected patients","volume":"16","author":"Andrade","year":"2021","journal-title":"PLoS One"},{"key":"R11-20250601","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R12-20250601","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/IDR.S326456","article-title":"Current perspectives on the diagnosis and management of healthcare-associated ventriculitis and meningitis","volume":"15","author":"Karvouniaris","year":"2022","journal-title":"Infect Drug Resist"},{"key":"R13-20250601","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40635-021-00385-9","article-title":"Point-of-care detection of lactate in cerebrospinal fluid","volume":"9","author":"Stephani","year":"2021","journal-title":"Intensive Care Med Exp"},{"key":"R14-20250601","first-page":"43","article-title":"High-mobility group box-1 protein as a novel biomarker to diagnose healthcare-associated ventriculitis and meningitis: a pilot study","volume":"87","author":"Piva","year":"2020","journal-title":"Minerva Anestesiol"},{"key":"R15-20250601","doi-asserted-by":"crossref","first-page":"e0265187","DOI":"10.1371\/journal.pone.0265187","article-title":"Outcomes of implementation of the FilmArray meningoencephalitis panel in a tertiary hospital between 2017 and 2020","volume":"17","author":"Teoh","year":"2022","journal-title":"PLoS One"},{"key":"R16-20250601","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00134-019-05815-7","article-title":"The comparison of Gram-positive and Gram-negative healthcare-associated ventriculitis and meningitis in adults and children","volume":"46","author":"Rogers","year":"2020","journal-title":"Intensive Care Med"},{"key":"R17-20250601","doi-asserted-by":"crossref","first-page":"e0025322","DOI":"10.1128\/spectrum.00253-22","article-title":"Carbapenem-resistant Gram-negative bacteria-related healthcare-associated ventriculitis and meningitis: antimicrobial resistance of the pathogens, treatment, and outcome","volume":"25","author":"Ye","year":"2022","journal-title":"Microbiol Spectr"},{"key":"R18-20250601","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1007\/s00701-016-2977-z","article-title":"Biofilm-associated infection: the hidden face of cerebrospinal fluid shunt malfunction","volume":"158","author":"Mounier","year":"2016","journal-title":"Acta Neurochir (Wien)"},{"key":"R19-20250601","doi-asserted-by":"crossref","first-page":"1415.e1","DOI":"10.1016\/j.cmi.2020.04.046","article-title":"Should we reconsider cefazolin for treating staphylococcal meningitis? A retrospective analysis of cefazolin and cloxacillin cerebrospinal fluid levels in patients treated for staphylococcal meningitis","volume":"26","author":"Le Turnier","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"R20-20250601","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13054-016-1523-y","article-title":"Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study","volume":"20","author":"Blassmann","year":"2016","journal-title":"Crit Care"},{"key":"R21-20250601","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"key":"R22-20250601","doi-asserted-by":"crossref","first-page":"e00190-19.","DOI":"10.1128\/CMR.00190-19","article-title":"Intrathecal antibacterial and antifungal therapies","volume":"33","author":"Nau","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"R23-20250601","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s12028-018-0647-0","article-title":"Current practices of intraventricular antibiotic therapy in the treatment of meningitis and ventriculitis: results from a multicenter retrospective cohort study","volume":"30","author":"Lewin","year":"2019","journal-title":"Neurocrit Care"},{"key":"R24-20250601","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijantimicag.2017.01.002","article-title":"Intrathecal or intraventricular administration of colistin, vancomycin and amikacin for central nervous system infections in neurosurgical patients in an intensive care unit","volume":"49","author":"Tsimogianni","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"R25-20250601","first-page":"781","article-title":"Comment on: multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments","volume":"75","author":"Perez-Alba","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"R26-20250601","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/QCO.0000000000000783","article-title":"Dose optimisation of antibiotics used for meningitis","volume":"34","author":"Heffernan","year":"2021","journal-title":"Curr Opin Infect Dis"},{"key":"R27-20250601","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s15010-020-01539-9","article-title":"Ceftazidime\/avibactam and ceftolozane\/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa postneurosurgical infections: three cases and a review of the literature","volume":"49","author":"Meschiari","year":"2021","journal-title":"Infection"},{"key":"R28-20250601","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/microorganisms10010154","article-title":"Real-time optimization of pharmacodynamic target attainment at infection site during treatment of post-neurosurgical ventriculitis caused by carbapenem-resistant Gram negatives with ceftazidime\u2013avibactam-based regimens: a report of two cases","volume":"10","author":"Gatti","year":"2022","journal-title":"Microorganisms"},{"key":"R29-20250601","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s15010-020-01510-8","article-title":"Continuous infusion of ceftolozane-tazobactam resulted in high cerebrospinal fluid concentrations of ceftolozane in a patient with multidrug-resistant Pseudomonas aeruginosa meningitis","volume":"49","author":"Winans","year":"2021","journal-title":"Infection"},{"issue":"(Suppl 1)","key":"R30-20250601","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ofid\/ofab466.1300","article-title":"1106. Evaluation of penetration of cefiderocol into cerebrospinal fluid using a rat meningitis model","volume":"8","author":"Takemura","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"R31-20250601","doi-asserted-by":"crossref","first-page":"dlab188","DOI":"10.1093\/jacamr\/dlab188","article-title":"Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections","volume":"3","author":"Meschiari","year":"2021","journal-title":"JAC-Antimicrobial Resist"},{"key":"R32-20250601","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhin.2015.09.014","article-title":"Silver-impregnated external-ventricular-drain-related cerebrospinal fluid infections: A meta-analysis","volume":"92","author":"Atkinson","year":"2016","journal-title":"J Hosp Infect"},{"key":"R33-20250601","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.wneu.2021.02.087","article-title":"Decreasing external ventricular drain infection rates in the neurocritical care unit: 12-year longitudinal experience at a single institution","volume":"150","author":"Walek","year":"2021","journal-title":"World Neurosurg"},{"key":"R34-20250601","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ajic.2019.10.012","article-title":"Impact of an educational program on reducing healthcare\u2013associated meningitis or ventriculitis in the neurosurgical intensive care unit","volume":"48","author":"Li","year":"2020","journal-title":"Am J Infect Control"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T22:02:54Z","timestamp":1748815374000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000001167","relation":{},"ISSN":["0952-7907","1473-6500"],"issn-type":[{"value":"0952-7907","type":"print"},{"value":"1473-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]}}}